��������

College of Science researcher Aarthi Narayanan recently secured a $1.4M grant from the Defense Threat Reduction Agency (DTRA) to investigate how an infection spreads between organs, and how a therapeutic will impact connected organs.

This week, areas close to �������� are experiencing a stunning and unusual view of the aurora borealis—also called the northern lights, thanks to Solar Cycle 25. Solar activity is ramping up. Find out what that means from George Mason expert Peter Becker, professor of astrophysics and space sciences.

With his 4-VA proposal “Nanoscale Visualization of Electrocatalytic Carbon Dioxide Reduction Activity at Cu Nanocatalysts,” Yun Yu wanted to investigate options in catalytic electrode materials to improve and enhance electrocatalysis, a process essential for harnessing sustainable energy sources for artificial photosynthesis.

A collaboration between the conflict analysis and resolution and geography and geoinformation science is giving scholars access to data that shows the breadth and depth of violence of the Sudanese Civil War: a key component of achieving justice in cases of human rights violations and war crimes.

George Mason scientist Fereshte Ghahari Kermani received the prestigious Early Career Development (CAREER) Program grant from the National Science Foundation to continue her research on the complex quantum phases in graphene materials.

��������’s popular FOCUS outreach program marks its 10th anniversary this summer and continues to expand its science and tech immersion programs.

Ian Candy is coming to George Mason from South Dakota to study government, neuroscience, and will compete in forensics. See how he hopes to combine it all in an effort to make the world a better place.

The user-inspired CropSmart Digital Twin provides on-demand, decision-ready solutions to take the guesswork out of crop management decisions.

As George Mason doctoral student Jericho McLeod reviewed literature on disease transmission as part of his PhD work, he and George Mason professor Eduardo López noticed a gap in the models and now seek to correct it.

Researchers in George Mason’s Center for Infectious Disease Research (CIDR) and Tulane National Primate Research Center conducted a breakthrough proof-of-concept study, published in Nature’s Gene Therapy, that found a human immunodeficiency virus (HIV)-like virus particle that could cease the need for lifelong medications.